We serve Chemical Name:[4-[2-(oxiran-2-yl)ethoxy]phenyl] 4-[2-(oxiran-2-yl)ethoxy]benzoate CAS:146063-25-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![[4-[2-(oxiran-2-yl)ethoxy]phenyl] 4-[2-(oxiran-2-yl)ethoxy]benzoate](https://a.dearchem.com/CAS2/146063-25-4.png)
Chemical Name:[4-[2-(oxiran-2-yl)ethoxy]phenyl] 4-[2-(oxiran-2-yl)ethoxy]benzoate
CAS.NO:146063-25-4
Synonyms:4-[2-(oxiran-2-yl)ethoxy]phenyl 4-[2-(oxiran-2-yl)ethoxy]benzoate
Molecular Formula:C21H22O6
Molecular Weight:370.39600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:548.2ºC at 760 mmHg
Density:1.257
Index of Refraction:1.581
PSA:69.82000
Exact Mass:370.14200
LogP:3.24120
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-[2-(oxiran-2-yl)ethoxy]phenyl 4-[2-(oxiran-2-yl)ethoxy]benzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[2-(oxiran-2-yl)ethoxy]phenyl 4-[2-(oxiran-2-yl)ethoxy]benzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[2-(oxiran-2-yl)ethoxy]phenyl 4-[2-(oxiran-2-yl)ethoxy]benzoate Use and application,4-[2-(oxiran-2-yl)ethoxy]phenyl 4-[2-(oxiran-2-yl)ethoxy]benzoate technical grade,usp/ep/jp grade.
Related News: The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said. [4-[2-(oxiran-2-yl)ethoxy]phenyl] 4-[2-(oxiran-2-yl)ethoxy]benzoate manufacturer Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. [4-[2-(oxiran-2-yl)ethoxy]phenyl] 4-[2-(oxiran-2-yl)ethoxy]benzoate supplier The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said. [4-[2-(oxiran-2-yl)ethoxy]phenyl] 4-[2-(oxiran-2-yl)ethoxy]benzoate vendor As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. [4-[2-(oxiran-2-yl)ethoxy]phenyl] 4-[2-(oxiran-2-yl)ethoxy]benzoate factory At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival.
